Navigation Links
Adding radiation decreases breast cancer recurrence

Radiotherapy after breast conserving surgery for breast cancer reduces recurrence and prevents development of additional breast tumors in older women with early stage breast disease, according to a new study. Published in the March 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that women also benefit from the recommended five years of tamoxifen treatment for hormone responsive tumors. Among women over 65 and treated with breast conserving surgery, the risk of local or regional recurrence increased up to 3.5 times if they did not receive radiation after their surgery.

Great strides have been made in breast cancer treatment. Breast conserving surgery in combination with radiotherapy and mastectomy provide women with two good options for their initial treatment. Augmenting surgery with hormone modulating drugs, such as tamoxifen, further improves survival and reduces recurrence.

Women over 65 are at the highest risk for breast cancer and make up half of those diagnosed. However, they are less likely to receive standard therapy, particularly radiotherapy after breast conserving surgery, than younger women. Making treatment recommendations for older patients, who may have more comorbidities than younger patients, is complicated by under-representation of older women in clinical trials and prognostic studies.

Led by Ann M. Geiger, M.P.H., Ph.D., of Wake Forest University School of Medicine and formerly of Kaiser Permanente Southern California, researchers retrospectively followed 1,837 women over 65 for ten years who were treated with surgery for early stage breast cancer to examine the impact of treatment on the occurrence of recurrent and additional breast tumors for this patient population. This analysis was part of a larger study led by Rebecca Silliman, M.D., Ph.D., of the Boston University Medical Center. It was conducted under the auspices of the National Cancer Institute-funded Can
'"/>

Source:John Wiley & Sons, Inc.


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Gene therapy may protect normal tissues during radiation retreatment for lung cancer
3. Jefferson researchers find nanoparticle shows promise in reducing radiation side effects
4. One therapeutic dose of radiation causes 30 percent spongy bone loss in mice
5. Gene therapy protects mice from the effects of whole-body irradiation
6. Cancer stem cells linked to radiation resistance
7. Mars mission Risk 29: Scientists research ways to reduce radiation-induced brain damage
8. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
9. New way of tracking muscle damage from radiation
10. Men with prostate cancer avoid radiation due to misconceptions
11. Researchers uncover protection mechanism of radiation-resistant bacterium

Post Your Comments:
(Date:11/25/2009)... assistant professors recently received funding fr...ue research beneficial to understanding the enviro...opher Blackwood, assistant professor in the Depart... support two separate research projects. , His f... Communities and Functions from the Leaf to the La...
(Date:11/24/2009)...sed a protein that may help gut bacteria bind to t...ed by probiotic producers to identify strains that...robiotics need to interact with cells lining the g... to surfaces in the gut they are more likely to st...ays Dr Nathalie Juge from the Institute of Food Re...
(Date:11/24/2009)... has long held secrets of the earth,s history lock...s been very little information on the environments...llions of years. Now, a team of researchers from n...to the tune of $10 million dollars by the National...of things literally. These scientists will drill ...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2Immune Response May Speed AIDS Progression in Women 51503 1Immune Response May Speed AIDS Progression in Women 51503 2Moderate Drinking Might Guard Against Alzheimers 51501 1Moderate Drinking Might Guard Against Alzheimers 51501 2Moderate Drinking Might Guard Against Alzheimers 51501 3Moderate Drinking Might Guard Against Alzheimers 51501 4Researchers gain insight into mechanism underlying Huntingtons 9240 1Researchers gain insight into mechanism underlying Huntingtons 9240 2
...have suspected that the three known domains of lif... off and went their separate ways around three bil...split has been an elusive task. , Now, a team of ...domains of life coexisted at least as long as 2.7 ...ical examination of shale samples, loaded with oil...
...ttle coal and processing the papermaking industry,...r choice than burning it for heat, improves the ca...n produce a fuel versatile enough to run a cooking...te engineers., "Black liquor is routinely burned ...or of fuel science. "But it has more energy value ...
...f end products including jet fuel, gasoline, carbo...sting refineries and combinations of coal and refi...e researchers., "One idea is based on the coal-to...time," says Caroline E. Burgess Clifford, research...aim is to integrate the processes and products int...
Other Biology News:Ancient organisms discovered in Canadian gold mine 2Coal and black liquor can produce energy from papermaking 2Coal-based fuels and products hit the refinery 2
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24...Nasdaq: DCGN ) today announced the approval of all... Court for the District of Delaware,(the "Bankrupt...ition for,relief under Chapter 11 of the United St..., The orders issued by the Bankruptcy Court...
(Date:11/24/2009)..., SEATTLE, Nov. 24 Blue Marble Ene... Odessa Public Development Authority (OPDA) were r...ommunity Economic Revitalization Board (CERB) in a...,s first specialty biochemical biorefinery in Linc...ificantly speed the development of our biorefinery...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall/ ...al specialty biopharmaceutical company, today,anno...Medicines Agency for,velaglucerase alfa, the compa... the treatment of Type 1 Gaucher disease. This is ...alfa that has been submitted, with previous,submis...
(Date:11/24/2009)... Program Connects Customers with Pa...llected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for...reparation, today announced its new global partner...nts for DNA Genotek,s partner community and is des...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...nology Network , Gov. Jim Doyle wrote about the ...ng our state,s economy. The governor missed the ma... of the best in the country. In order to remain on...ate and evolve, something it has done little of si... Board of Regents have shown they are not open to...
...s reached an agreement to install clinical informa..., a Milwaukee-based medical informatics company. ,... to integrate all of Marshfield,s clinical data, i...ribute them within the clinic,s electronic medical...field Clinic,s healthcare professionals through In...
...his life-science company, GenTel BioSciences , ha...tein chip platform from GlaxoSmithKline , but jus...e technology improves the quality of data GenTel d...ped a protein chip used by cancer researchers, ann... new facility in the Fitchburg Technology Campus ...
Other Biology Technology:UW System must remove barriers to innovation 2UW System must remove barriers to innovation 3UW System must remove barriers to innovation 4GenTel acquires GlaxoSmithKline chip platform 2GenTel acquires GlaxoSmithKline chip platform 3
Rabbit Anti-Myosin VIIa Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-GPCR G2A Polyclonal Antibody, Unconjugated from Abcam
Anti-6-keto Prostaglandin F1 alpha (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
BD FACSCanto flow cytometer from BD Biosciences - Immunocytometry Systems
Biology Products: